retatrutide to tirzepatide vs Compared Switching From Tirzepatide to Retatrutide

GLP-1 is the same gut hormone targeted by semaglutide (Ozempic) medications it slows gastric emptying, reduces appetite, and improves insulin sensitivity

Food and Drug Administration (FDA) for medical, diagnostic, or therapeutic use

Review bloodwork, assess side effects, discuss dose optimization, and evaluate progress against expectations

First GLP-1 pill of its kind with flexible dosing Can be taken at any time of day No fasting or timing requirements Removes one of the biggest barriers vs injectable therapies Clinical impact (ATTain-1 trial): ~27 lbs average weight loss at highest dose ~12.4% body weight reduction Significant improvements in cardiometabolic markers (cholesterol, blood pressure, waist circumference) Weve seen explosive growth in GLP-1 injectables but: Many patients delay or avoid treatment due to injections Adherence can be a challenge Access and convenience remain barriers A simple oral option could expand the market significantly and reach patients earlier in their journey

This article makes no claim that Telos Rx has been the subject of any such enforcement action

In this study, measurements of DXA revealed that total fat mass percentage and android/ginoid ratio decreased with liraglutide 3.0 mg/day compared with placebo